Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.

Slides:



Advertisements
Similar presentations
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Advertisements

Prior Trials of RAAS Inhibitors
Immunotherapies: Key Considerations in the Identification and Management of irAEs.
Emerging Concepts in Heart Failure
Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Statin Selection in the Elderly
Current State of Hyperkalemia Management
NOACs for Cancer-Associated Thrombosis:
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Starting Strong: Initial Evaluation of the Patient With HCV
PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.
Optimizing Therapy for Osteoarthritis
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Rate, HF Admissions, and Readmissions
New Therapies for Hyperkalemia Across the Continuum of Care
A CASE CHALLENGE IN HFrEF:
Does One Size Fit All in Obesity Management?
UNDERSTANDING RISK STRATIFICATION IN PAH:
At The Cutting Edge of Developments in the Management of Hyperkalemia
Updates Abound in Hyperkalemia Management
PCP Perspectives Clinical Considerations in Hyperkalemia
Case Study: 45-year-old Man
Thank you for taking the preassessment
What Do We Know About LDL-C?
Addressing Iron Deficiency in Chronic HF
Tailoring Hemophilia Prophylaxis Therapy
Time to Take Gout Seriously
Expert Perspectives on Hyperkalemia for the Specialist
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Multidisciplinary Perspectives on Interstitial Lung Diseases
Exploring Emerging Treatments for Hyperkalemia
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
At The Cutting Edge of Developments in the Management of Hyperkalemia
Expert Insights on Complex Clinical Cases of Edema
Risk Stratification in CAD and PAD
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Practical Strategies to Reduce HF Hospitalizations in African American Patients.
Personalized Therapy in Relapsed or Refractory CLL
Multidisciplinary Management of Hyperkalemia:
Hyperkalemia in the Hospital
Overcoming Clinical Inertia
Clinicians' Corner in Dyslipidemia
Shifting Currents in Hyperkalemia Management 2015 in Review
Shifting Currents in Hyperkalemia Management 2015 in Review
CAD and HF Often Coexist
Hepatitis C: After the Diagnosis
New Strategies to Reduce HF Readmissions
Managing HF in Primary Care
Iron Deficiency in Heart Failure
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.
Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.
Assessing the Burden of Hyperkalemia
Breaking Down the Data in Hyperkalemia
Contemporary Considerations in Biomarker-Guided Therapy
Assessing the Burden of Hyperkalemia
PCSK9 Inhibitors and Statin Intolerance
Evaluating the Science of Cardiogenic Shock
Uptitration of Medications in HF: Start Low but Aim High and Stay High
Clinical Comparisons.
Expert Perspectives.
Key Data on Improving Outcomes in HF Patients
Treatment Advances for RA
RAASi Enabling in the Modern Era
PCSK9 Inhibitors and Real-World Evidence
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Potassium Situations Resolved
Presentation transcript:

Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management

Patient Case 48-Year-Old Black Man

Consultation for Better BP Control

Follow-Up a Month Later

Next Follow-Up a Month Later

Long-Term Regimen

At What Level of K+ Should One Start Getting Concerned?

Relationship Between Potassium Level and Risk of Mortality

Guidelines Recommendations Regarding RAAS Inhibitor Use Based on Serum Potassium Level

Relationship Between Potassium Level and Patient Outcome

Diuretic Support

Maintaining Euvolemia in HF

Considerations When Starting RAAS inhibitors

High-Potassium-Containing Foods

Potassium Binders

Studies Evaluating the Efficacy and Safety of SZC and Patiromer

Uptake of Potassium Binders in Clinical Practice

Multidisciplinary Team Approach to Managing Hyperkalemia

Abbreviations

Abbreviations (cont)